It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Bacterial species are able to colonize and establish communities in biotic and abiotic surfaces. Moreover, within the past five decades, incidence of bacterial strains resistant to currently used antibiotics has increased dramatically. This has led to diverse health issues and economical losses for different industries. Therefore, there is a latent need to develop new and more efficient antimicrobials. This work reports an increased production of an exopolysaccharide in a native yeast strain isolated from the Mexican Northeast, Rhodotorula mucilaginosa UANL-001L, when co-cultured with E. coli. The exopolysaccharide produced is chemically and physically characterized and its applications as an antimicrobial and antibiofilm are explored. The exopolysaccharide is capable of inhibiting planktonic growth and biofilm formation in Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Additionally, the exopolysaccharide studied here does not exhibit cytotoxic effects when assessed both, in vitro against an H9c2 mammalian cell line, and in vivo in a murine toxicity model. Taken together, the properties of this exopolysaccharide indicate that it has potential applications to inhibit bacterial colonization in medical and industrial settlings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Universidad Autónoma de Nuevo León, Facultad de Ciencias Químicas, San Nicolas de los Garza, Nuevo León, Mexico; Centro de Investigacion en Biotecnologia y Nanotoxicologia, Facultad de Ciencias Quimicas, Universidad Autonoma de Nuevo Leon. Parque de Investigacion e Innovacion Tecnologica, Km. 10 autopista al Aeropuerto Internacional Mariano Escobedo, Apodaca, Nuevo Leon, Mexico
2 Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, San Nicolas de los Garza, Nuevo León, Mexico
3 Cátedra de Cardiología y Medicina Vascular. Escuela de Medicina. Tecnologico de Monterrey, Monterrey, Nuevo León, Mexico; Centro de Investigación Biomédica. Hospital Zambrano-Hellion. Tecnologico de Monterrey, San Pedro Garza-Garcia, Nuevo León, Mexico
4 Universidad Autónoma de Nuevo León, Facultad de Ciencias Químicas, San Nicolas de los Garza, Nuevo León, Mexico